Published in Ann Rheum Dis on May 01, 1999
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis (2008) 2.61
Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents. Clin Rheumatol (2004) 0.90
Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area. Ann Rheum Dis (2001) 0.83
Follow up studies in rheumatoid arthritis. Ann Rheum Dis (2002) 0.78
Ex vivo effect of gold nanoparticles on porcine synovial membrane. Tissue Barriers (2013) 0.75
[Methotrexate]. Z Rheumatol (2016) 0.75
[Gold as an alternative in the treatment of RA patients with malignancies]. Z Rheumatol (2016) 0.75
1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis (1958) 24.41
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) (1977) 9.55
The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum (1990) 2.67
Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med (1974) 2.47
Gold therapy in early rheumatoid arthritis. Ann Intern Med (1950) 2.30
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (1996) 2.30
Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol (1990) 1.62
Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum (1992) 1.51
Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum (1992) 1.46
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum (1997) 1.45
Clinical responses during gold therapy for rheumatoid arthritis. Changes in synovitis, radiologically detectable erosive lesions, serum proteins, and serologic abnormalities. Arthritis Rheum (1982) 1.43
How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions. J Rheumatol (1995) 1.40
Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol (1977) 1.35
A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol (1998) 1.35
Association between gold induced skin rash and remission in patients with rheumatoid arthritis. Ann Rheum Dis (1989) 1.11
Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol (1989) 1.09
Long-term treatment of destructive rheumatoid arthritis with methotrexate. J Rheumatol (1997) 1.05
Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am J Med (1983) 1.04
Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness. J Rheumatol (1995) 1.01
Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients. Semin Arthritis Rheum (1985) 0.99
The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis. Clin Rheumatol (1984) 0.98
Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases. J Rheumatol (1991) 0.97
Long-term chrysotherapy in rheumatoid arthritis. Arthritis Rheum (1979) 0.96
Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol (1993) 0.96
Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients. Ann Rheum Dis (1995) 0.96
A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis. Br J Rheumatol (1998) 0.94
Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients. Br J Rheumatol (1997) 0.94
Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation. Ann Rheum Dis (1997) 0.92
A multicentre controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage. Agents Actions (1976) 0.89
A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis. J Rheumatol (1988) 0.89
Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial. J Rheumatol (1989) 0.86
Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol (1998) 0.83
Methotrexate treatment of rheumatoid arthritis: effects on radiological progression. Scand J Rheumatol (1989) 0.82
The second course of gold. J Rheumatol (1995) 0.81
Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate. Ann Rheum Dis (1992) 0.79
Erosion number and area progression in the wrists and hands of rheumatoid patients: a quantitative microfocal radiographic study. Ann Rheum Dis (1989) 0.78
Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis. J Rheumatol (1994) 0.77
Can treatment with methotrexate influence the radiological progression of rheumatoid arthritis? Clin Rheumatol (1990) 0.77
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
A new obligately chemolithoautotrophic, nitrite-oxidizing bacterium, Nitrospira moscoviensis sp. nov. and its phylogenetic relationship. Arch Microbiol (1995) 4.02
Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol (2001) 2.54
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum (2000) 2.29
Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol (1998) 2.22
Treatment continuation in patients receiving biological agents or conventional DMARD therapy. Ann Rheum Dis (2005) 2.15
Molecular forms of acetylcholine receptor. Effects of calcium ions and a sulfhydryl reagent on the occurrence of oligomers. Biochemistry (1977) 1.98
[Therapy of ankylosing spondylitis (AS) with radium chloride (224SpondylAT)]. Z Rheumatol (2001) 1.82
The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene (2001) 1.72
Nitrification at Low pH by Aggregated Chemolithotrophic Bacteria. Appl Environ Microbiol (1991) 1.68
Glial cells express N-CAM/D2-CAM-like polypeptides in vitro. Nature (1985) 1.66
Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. J Rheumatol (1989) 1.64
Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease-modifying antirheumatic drug therapy. Arthritis Rheum (1996) 1.64
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Ann Rheum Dis (2003) 1.64
Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. A controlled study. Arthritis Rheum (1991) 1.61
Identification and quantitation of antigens and antibodies by means of quantitative immunoelectrophoresis. A survey of methods. J Immunol Methods (1972) 1.58
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group. J Rheumatol (2000) 1.49
Demonstration of immunochemical identity between the nerve growth factor-inducible large external (NILE) glycoprotein and the cell adhesion molecule L1. EMBO J (1985) 1.46
Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res (1990) 1.46
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. Clin Rheumatol (1996) 1.42
The neural cell adhesion molecule L1 is distinct from the N-CAM related group of surface antigens BSP-2 and D2. EMBO J (1984) 1.40
Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway. J Neurosci (2000) 1.38
Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford) (2002) 1.37
A simple procedure for quantification of neurite outgrowth based on stereological principles. J Neurosci Methods (2000) 1.36
A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol (1998) 1.35
Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford) (1999) 1.33
Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem (2000) 1.29
Growth of nitrobacter in the presence of organic matter. II. Chemoorganotrophic growth of Nitrobacter agilis. Arch Microbiol (1976) 1.25
Comparison of antigens: the reaction of 'identity'. Scand J Immunol Suppl (1973) 1.25
High rate of aerobic nitrification and denitrification by Nitrosomonas eutropha grown in a fermentor with complete biomass retention in the presence of gaseous NO2 or NO. Arch Microbiol (1998) 1.24
The first immunoglobulin-like neural cell adhesion molecule (NCAM) domain is involved in double-reciprocal interaction with the second immunoglobulin-like NCAM domain and in heparin binding. J Biol Chem (1997) 1.22
Intermediate filaments regulate astrocyte motility. J Neurochem (2001) 1.21
Biosynthesis of the neural cell adhesion molecule: characterization of polypeptide C. J Cell Biol (1985) 1.20
The three-dimensional structure of the first domain of neural cell adhesion molecule. Nat Struct Biol (1996) 1.20
Immunohistochemical demonstration of S-100 protein and GFA protein in interstitial cells of rat pineal gland. Brain Res (1978) 1.19
The cell adhesion molecule Cell-CAM 105 is an ecto-ATPase and a member of the immunoglobulin superfamily. FEBS Lett (1990) 1.16
Icosahedral inclusions (carboxysomes) of Nitrobacter agilis. J Bacteriol (1977) 1.15
The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system. Exp Gerontol (1999) 1.14
Nervous system specific proteins. J Neurochem (1978) 1.14
Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. Neurology (1982) 1.13
A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol (1995) 1.12
A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35. Neuroscience (2007) 1.11
Growth of Nitrobacter in the presence of organic matter. I. Mixotrophic growth. Arch Microbiol (1976) 1.10
A method to score radiographic change in psoriatic arthritis. Z Rheumatol (2001) 1.10
Biosynthesis of the D2-cell adhesion molecule: post-translational modifications, intracellular transport, and developmental changes. J Cell Biol (1984) 1.09
Ecto-protein kinase activity on the external surface of neural cells. Nature (1986) 1.09
Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-cadherin. Cell Mol Life Sci (2008) 1.09
[Imaging techniques in rheumatology: magnetic resonance imaging in rheumatoid arthritis]. Z Rheumatol (2003) 1.08
[Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study]. Z Rheumatol (1998) 1.07
Cell adhesion molecules in neural development. Dev Neurosci (1989) 1.07
Close genetic relationship between Nitrobacter hamburgensis nitrite oxidoreductase and Escherichia coli nitrate reductases. Arch Microbiol (1993) 1.06
Purification of the synaptic membrane glycoprotein D2 from rat brain. Scand J Immunol (1982) 1.05
Long-term treatment of destructive rheumatoid arthritis with methotrexate. J Rheumatol (1997) 1.05
Structure and interactions of NCAM modules 1 and 2, basic elements in neural cell adhesion. Nat Struct Biol (1999) 1.05
Nitrosovibrio spp., the Dominant Ammonia-Oxidizing Bacteria in Building Sandstone. Appl Environ Microbiol (1989) 1.04
Biosynthesis of the D2 cell adhesion molecule: pulse-chase studies in cultured fetal rat neuronal cells. J Cell Biol (1984) 1.04
[Allergic-toxic liver damage due to D-penicillamine]. Schweiz Med Wochenschr (1972) 1.03
Brain specific synaptosomal membrane proteins demonstrated by crossed immunoelectrophoresis. J Neurochem (1974) 1.03
Structural basis of cell-cell adhesion by NCAM. Nat Struct Biol (2000) 1.03
Dystrophin in electric organ of Torpedo californica homologous to that in human muscle. J Biol Chem (1989) 1.02
Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas. Mol Endocrinol (1992) 1.01
Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol (2004) 1.00
The neural cell adhesion molecule in synaptic plasticity and ageing. Int J Dev Neurosci (2000) 1.00
Biochemical and ultrastructural studies of cultured rat astroglial cells: effect of brain extract and dibutyryl cyclic AMP on glial fibrillary acidic protein and glial filaments. Differentiation (1980) 1.00
Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity. Int J Cancer (1989) 1.00
Ductus arteriosus aneurysm in an adult. AJR Am J Roentgenol (1984) 0.99
Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology (Oxford) (2002) 0.99
High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus. J Neurol Sci (1985) 0.97
Enzymatic studies on autotrophically, mixotrophically and heterotrophically grown Nitrobacter agilis with special reference to nitrite oxidase. Arch Microbiol (1977) 0.97
The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years. J Rheumatol (2000) 0.96
Pitfalls in the use of commercial nonionic detergents for the solubilization of integral membrane proteins: sulfhydryl oxidizing contaminants and their elimination. Anal Biochem (1980) 0.96
1H and 13C nuclear magnetic resonance studies of plasma from patients with primary intracranial neoplasms. J Neurosurg (1988) 0.96
[Characterization of a phage-like particle from cells of Nitrobacter. I. Host-particle correlation and particle isolation (author's transl)]. Arch Microbiol (1974) 0.96
Enzyme-linked immunosorbent assay of the D2-glycoprotein. J Neurochem (1983) 0.95
Significance of gaseous NO for ammonia oxidation by Nitrosomonas eutropha. Antonie Van Leeuwenhoek (2000) 0.95
Cell-cycle-dependent regulation of cell motility and determination of the role of Rac1. Exp Cell Res (2004) 0.95
A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis. Br J Rheumatol (1998) 0.94
Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients. Br J Rheumatol (1997) 0.94
Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience (2007) 0.93
Different isoforms and stock-specific variants of the cell adhesion molecule C-CAM (cell-CAM 105) in rat liver. Eur J Biochem (1993) 0.93
NCAM-antibodies modulate induction of long-term potentiation in rat hippocampal CA1. Brain Res (1995) 0.92
Antigen-antibody crossed electrophoresis of water-soluble rat brain antigens. J Neurochem (1971) 0.92
[Characterization of a phage-like particle from cells of Nitrobacter. III. On the DNA-content]. Arch Microbiol (1974) 0.92
Antigens in human glioblastomas and meningiomas: Search for tumour and onco-foetal antigens. Estimation of S-100 and GFA protein. Br J Cancer (1977) 0.92
A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol (1991) 0.92
Ammonia oxidation by Nitrosomonas eutropha with NO(2) as oxidant is not inhibited by acetylene. Microbiology (2001) 0.91
Antigen-antibody crossed electrophoresis of rat brain synaptosomes and synaptic vesicles: correlation to water-soluble antigens from rat brain. J Neurochem (1974) 0.91
Identification of nitrite-oxidizing bacteria with monoclonal antibodies recognizing the nitrite oxidoreductase. Appl Environ Microbiol (1999) 0.91
Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) (2008) 0.90
Identification of an amino acid sequence motif in the cytoplasmic domain of the NCAM-140 kDa isoform essential for its neuritogenic activity. J Neurochem (2000) 0.90
Characterization of the kinetics of neural cell adhesion molecule homophilic binding. FEBS Lett (1988) 0.90
Anaerobic ammonia oxidation by cell-free extracts of Nitrosomonas eutropha. Antonie Van Leeuwenhoek (1998) 0.90